PUBLIC HEALTH INFORMATION:

STUDENTS - PLEASE READ THE FOLLOWING PUBLIC HEALTH INFORMATION FOR YOUR PERSONAL HEALTH AND SAFETY SO THAT YOU ARE WELL INFORMED ABOUT BOTH MENINGCOCCAL DISEASE AND TUBERCULOSIS.

 


◆ Meningococcal disease is a serious disease, caused by a bacteria.

◆ Meningococcal disease is a contagious, but a largely preventable, infection of the spinal cord fluid and the fluid that surrounds the brain. Meningococcal disease can also cause blood      infections.

◆ About 2,600 people get meningococcal disease each year in the United States; 10 to 15 percent of these people die, in spite of treatment with antibiotics. Of those who live, another 10 percent lose their arms or legs, become deaf, have problems with their nervous system, become mentally retarded, or suffer seizures or strokes.

◆ Anyone can get meningococcal disease, but it is most common in infants less than one year of age and in people with certain medical conditions. Scientific evidence suggests that college students living in dormitory facilities are at a modestly increased risk of contracting meningococcal disease.

◆ Immunization against meningococcal disease decreases the risk of contracting the disease. Meningococcal vaccine can prevent four types of meningococcal disease; these include two of the three most common in the United States. Meningococcal vaccine cannot prevent all types of the disease, but it does help to protect many people who might become sick if they do not get the vaccine.

◆ A vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of the meningococcal vaccine causing serious harm, or death, is extremely small. Getting a meningococcal vaccine is much safer than getting the disease.

◆ More information can be obtained from the Vaccine Information Statement available at www.cdc.gov. Students and their parents should discuss the risks and benefits of vaccination with their health care providers.

◆ For a list of public health departments/agencies in Colorado, go tohttps://www.colorado.gov/pacific/cdphe/find-your-local-public-health-agency  

 For more immunization information www.cdc.gov/vaccines/pubs/vis/default.htm

Students: Please answer the following questions. If you answer “YES” to any of the questions and/or have any of the symptoms listed in question #7, you should consult with a medical provider as soon as possible since you may be at greater risk for contracting TB or in need of additional medical evaluation(s). 

1. Are you from or have you lived for two months or more in Asia, Africa, Central or South America or Eastern Europe?

2. Have you been diagnosed with a chronic condition that may impair your immune system?

3. Have you resided/worked/volunteered in a prison/hospital/nursing home/homeless shelter/long term treatment center?

4. Have you ever had contact with a person known to have active tuberculosis?

5. Have you ever used injection drugs?

6. Have you ever had a positive (reactive) tuberculin skin test for tuberculosis?

7. Do you currently have any of the following symptoms …

cough of greater than 3 weeks * night sweats * shortness of breath * loss of appetite * a productive cough weight loss * unexplained fatigue * weakness * unexplained fever * chest pain * chills *  or are you coughing up blood?

PLEASE NOTE:
In order to view the experts guide, you need to have
Adobe Reader installed on your computer.

Click here to download and install the FREE Adobe Reader

Documents may be obtained in an alternative format (i.e. large print, Braille, or e-text) by contacting the ACCESS Center for Disability Accommodations & Adaptive Technology at 303-556-8387, Plaza Building, Suite 122.

PLEASE NOTE:

In order to view the experts guide, you need to have
Adobe Reader installed on your computer.

Click here to download and install the FREE Adobe Reader

Documents may be obtained in an alternative format (i.e. large print, Braille, or e-text) by contacting the ACCESS Center for Disability Accommodations & Adaptive Technology at 303-556-8387, Plaza Building, Suite 122.